209 related articles for article (PubMed ID: 24077928)
1. Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men: Perspectives of PrEP users and high-risk PrEP naïve men.
Wade Taylor S; Mayer KH; Elsesser SM; Mimiaga MJ; O'Cleirigh C; Safren SA
AIDS Behav; 2014 May; 18(5):871-9. PubMed ID: 24077928
[TBL] [Abstract][Full Text] [Related]
2. Sexual partnerships and considerations for HIV antiretroviral pre-exposure prophylaxis utilization among high-risk substance using men who have sex with men.
Mimiaga MJ; Closson EF; Kothary V; Mitty JA
Arch Sex Behav; 2014 Jan; 43(1):99-106. PubMed ID: 24243002
[TBL] [Abstract][Full Text] [Related]
3. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
[TBL] [Abstract][Full Text] [Related]
4. Assessing determinants of pre-exposure prophylaxis (PrEP) adherence among a sample of rural Midwestern men who have sex with men (MSM).
Owens C; Hubach RD; Lester JN; Williams D; Voorheis E; Reece M; Dodge B
AIDS Care; 2020 Dec; 32(12):1581-1588. PubMed ID: 32338061
[TBL] [Abstract][Full Text] [Related]
5. Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: a qualitative study.
Closson EF; Mitty JA; Malone J; Mayer KH; Mimiaga MJ
AIDS Care; 2018 Feb; 30(2):191-198. PubMed ID: 28830220
[TBL] [Abstract][Full Text] [Related]
6. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP
AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706
[TBL] [Abstract][Full Text] [Related]
7. Acceptability of an "on-demand" pre-exposure HIV prophylaxis trial among men who have sex with men living in France.
Lorente N; Fugon L; Carrieri MP; Andreo C; Le Gall JM; Cook E; Aboulker JP; Capitant C; Molina JM; Spire B
AIDS Care; 2012; 24(4):468-77. PubMed ID: 22085083
[TBL] [Abstract][Full Text] [Related]
8. The Use of Online Posts to Identify Barriers to and Facilitators of HIV Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men: A Comparison to a Systematic Review of the Peer-Reviewed Literature.
Hannaford A; Lipshie-Williams M; Starrels JL; Arnsten JH; Rizzuto J; Cohen P; Jacobs D; Patel VV
AIDS Behav; 2018 Apr; 22(4):1080-1095. PubMed ID: 29285638
[TBL] [Abstract][Full Text] [Related]
9. A Qualitative Study of Medical Mistrust, Perceived Discrimination, and Risk Behavior Disclosure to Clinicians by U.S. Male Sex Workers and Other Men Who Have Sex with Men: Implications for Biomedical HIV Prevention.
Underhill K; Morrow KM; Colleran C; Holcomb R; Calabrese SK; Operario D; Galárraga O; Mayer KH
J Urban Health; 2015 Aug; 92(4):667-86. PubMed ID: 25930083
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Benin: a qualitative study.
Ahouada C; Diabaté S; Gning NN; Hessou S; Batona G; Guédou FA; Béhanzin L; Zannou MD; Alary M
AIDS Care; 2020 Feb; 32(2):242-248. PubMed ID: 31129988
[TBL] [Abstract][Full Text] [Related]
11. Knowledge and Acceptability of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Ghana.
Ogunbajo A; Leblanc NM; Kushwaha S; Boakye F; Hanson S; Smith MDR; Nelson LE
AIDS Care; 2020 Mar; 32(3):330-336. PubMed ID: 31597455
[TBL] [Abstract][Full Text] [Related]
12. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City.
Golub SA; Gamarel KE; Rendina HJ; Surace A; Lelutiu-Weinberger CL
AIDS Patient Care STDS; 2013 Apr; 27(4):248-54. PubMed ID: 23565928
[TBL] [Abstract][Full Text] [Related]
13. Vulnerable infected populations and street markets for ARVs: Potential implications for PrEP rollout in the USA.
Kurtz SP; Buttram ME; Surratt HL
AIDS Care; 2014 Apr; 26(4):411-5. PubMed ID: 24033118
[TBL] [Abstract][Full Text] [Related]
14. Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) and Implementation Challenges Among Men Who Have Sex with Men in India: A Qualitative Investigation.
Chakrapani V; Newman PA; Shunmugam M; Mengle S; Varghese J; Nelson R; Bharat S
AIDS Patient Care STDS; 2015 Oct; 29(10):569-77. PubMed ID: 26348459
[TBL] [Abstract][Full Text] [Related]
15. Persistent stigmatizing and negative perceptions of pre-exposure prophylaxis (PrEP) users: implications for PrEP adoption among Latino men who have sex with men.
Brooks RA; Nieto O; Landrian A; Donohoe TJ
AIDS Care; 2019 Apr; 31(4):427-435. PubMed ID: 30021456
[TBL] [Abstract][Full Text] [Related]
16. Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men (MSM): A Scoping Review on PrEP Service Delivery and Programming.
Hillis A; Germain J; Hope V; McVeigh J; Van Hout MC
AIDS Behav; 2020 Nov; 24(11):3056-3070. PubMed ID: 32274670
[TBL] [Abstract][Full Text] [Related]
17. Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study.
Franks J; Hirsch-Moverman Y; Loquere AS; Amico KR; Grant RM; Dye BJ; Rivera Y; Gamboa R; Mannheimer SB
AIDS Behav; 2018 Apr; 22(4):1139-1149. PubMed ID: 29143163
[TBL] [Abstract][Full Text] [Related]
18. Adherence to pre-exposure prophylaxis among men who have sex with men: A prospective cohort study.
Qu D; Zhong X; Xiao G; Dai J; Liang H; Huang A
Int J Infect Dis; 2018 Oct; 75():52-59. PubMed ID: 30125688
[TBL] [Abstract][Full Text] [Related]
19. Motives of Dutch men who have sex with men for daily and intermittent HIV pre-exposure prophylaxis usage and preferences for implementation: A qualitative study.
Bil JP; van der Veldt WM; Prins M; Stolte IG; Davidovich U
Medicine (Baltimore); 2016 Sep; 95(39):e4910. PubMed ID: 27684827
[TBL] [Abstract][Full Text] [Related]
20. Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand.
Tangmunkongvorakul A; Chariyalertsak S; Amico KR; Saokhieo P; Wannalak V; Sangangamsakun T; Goicochea P; Grant R
AIDS Care; 2013 Aug; 25(8):961-7. PubMed ID: 23252473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
